Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

189.29 -1.44 (-0.75%)
Streaming Delayed Price Updated: 10:11 AM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biogen Idec

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
48 49 Next >
News headline image
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help ↗
Today's depression drugs don't fit many patients' needs. Biotech companies may change that. 
Via Investor's Business Daily
News headline image
Is This Company In A Special Position Even As The COVID-19 Pandemic Affects Cell-Based Therapy Industry? ↗
According to Grand View Research, the global cell therapy market was valued at $7.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.5% between 2021 and 2028. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
7 Cheap Blue-Chip Stocks to Buy Before They Rebound ↗
The bear market has hit even top firms. That means investors should consider these cheap blue-chip stocks to buy now. 
Via InvestorPlace
News headline image
Biogen (BIIB) Stock Dips Following Q2 Earnings Report ↗
Biogen delivered a Q2 beat on the top and bottom lines, but a lack of important disclosures is hurting sentiment for BIIB stock. 
Via InvestorPlace
News headline image
Earnings Beat, Increased FY22 Outlook, Rising Biosimilar Competition: Biogen's Q2 Highlights ↗
 
Via Benzinga
News headline image
Recap: Biogen Q2 Earnings ↗
  Biogen (NASDAQ:BIIB) reported its Q2 earnings results on Wednesday, July 20, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Biogen Stock Falls Despite Beat-And-Raise Q2 Report ↗
Biogen stock fell early Wednesday after the biotech company reported adjusted profit of $5.25 per share on sales $2.59 billion in Q2. 
Via Investor's Business Daily
News headline image
How Is The Market Feeling About Biogen? ↗
Biogen's (NASDAQ:BIIB) short percent of float has fallen 17.34% since its last report. The company recently reported that it has 2.09 million shares sold short, which is 1.43% of... 
Via Benzinga
News headline image
Bill Gates, Jeff Bezos Unite To 'Change The Course' Of Neurological Disorder Impacting 6.5 Million Americans ↗
It’s a well-known fact that Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates, through his Bill & Melinda Gates Foundation, is working toward eliminating infectious diseases and eradicating... 
Via Benzinga
News headline image
Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today ↗
Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 2.68% on an annualized basis producing an average annual return of 9.81%. Currently, Biogen has a market capitalization of... 
Via Benzinga
News headline image
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea ↗
Pasithea Therapeutics Corp. (NASDAQ: KTTA), a biotech company looking for new treatments for psychiatric and neurological disorders, received an AU$1 million (US$694,000) gran 
Via Benzinga
News headline image
7 Undervalued S&P 500 Stocks to Buy Before Wall Street Catches On ↗
July's heat on Wall Street could start to sizzle in August with these undervalued S&P 500 stocks that are ready to buy. 
Via InvestorPlace
News headline image
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary ↗
 
Via Benzinga
News headline image
FDA Accepts Biogen's Submission For Neurodegenerative Disease Drug Under Priority Review ↗
The U.S. Food and Drug Administration (FDA) has accepted Biogen’s (NASDAQ: BIIB) New Drug Application (NDA) for its lead asset Tofersen for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis... 
Via Benzinga
News headline image
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
As Snap Spooks Market, Here Are The Hits & Misses Of Q2 Reporting Season ↗
Snap, Inc. (NYSE: SNAP) was among the high-profile disappointment thus far in the second-quarter reporting season. 
Via Benzinga
News headline image
Biogen Whale Trades Spotted ↗
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
News headline image
With All Eyes On Lecanemab Read Out In Alzheimer's, Uncertainty Overshadows Biogen's Q2 Beat ↗
 
Via Benzinga
News headline image
Benzinga Before The Bell: Baidu Beats Tesla, Finland Sells $47.5M Bitcoins, Tesla's Bitcoin Sale And Other Top Financial Stories Thursday, July 21 ↗
CNBC 
Via Benzinga
News headline image
Tesla to $1,175? Here Are 5 Other Price Target Changes for Thursday ↗
Mizuho raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,150 to $1,175. However, Mizuho analyst Vijay Rakesh maintained a Buy rating on the stock. Tesla shares rose 3.3% to $766.88 in pre-market... 
Via Benzinga
News headline image
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday ↗
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. 
Via Benzinga
News headline image
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial ↗
Biogen, Inc. (NASDAQ: BIIB) disclosed in its second-quarter earnings report that it recorded $900 million related to a settlemen 
Via Benzinga
News headline image
Stranger Things Do Happen As Netflix Surprises Investors ↗
(Wednesday Market Open) The European Commission (EU) has asked its 27 member nations to reduce their natural gas consumption by 15% between August and March 2023. The announcement turned U.S. equity... 
Via Benzinga
News headline image
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Biogen Inc. Q2 Earnings And Revenues Surpass Estimates ↗
Biogen Inc. came out with quarterly earnings of $5.25 per share. 
Via Talk Markets
News headline image
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches ↗
More than 55 million people worldwide have dementia — with about 60% to 70% of those cases resulting from Alzheimer’s disease — and that number is expected to triple by 2050. 
Via Benzinga
News headline image
Investors Turn Their Attention To The Earning Season ↗
US stock indices rose on Tuesday as investors temporarily put aside recession fears and dived into the reporting season. 
Via Talk Markets
News headline image
Netflix Earnings NFLX In Motion - What Levels are in Play and also for Tesla TSLA Tomorrow? ↗
Netflix reported earnings right after the bell Tuesday and shares surged right on the announcement - but will they hold going into Wednesday morning? 
Via Talk Markets
News headline image
Earnings Scheduled For July 20, 2022 ↗
Companies Reporting Before The Bell • Wipro (NYSE:WIT) is projected to report quarterly earnings at $0.08 per share on revenue of $2.80 billion. 
Via Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.